Grants and Contracts per year
Personal profile
Education/Academic qualification
Master of Science, University Of North Carolina
2001
Post Doctoral Fellow, Duke University
2001
Residency, University Of Rochester
1998
Doctor of Medicine, Medical College of Ohio
1995
Bachelor of Science, Bowling Green State University
1990
-
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.
6/28/19 → 9/7/24
Project: Research project
-
An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Sorge, C., Radulescu, V. & Shaw, A.
Childrens Hospital of Philadelphia
12/4/19 → 3/9/22
Project: Research project
-
AHOD1822: An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Sorge, C., Radulescu, V. & Shaw, A.
12/4/19 → 2/15/23
Project: Research project
-
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.
Childrens Hospital of Philadelphia
6/28/19 → 1/13/22
Project: Research project
-
Residual Scope: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.
6/28/19 → 11/10/22
Project: Research project